Home » GSK’s Target: 200 Rare Diseases
GSK’s Target: 200 Rare Diseases
Pharmaceutical giant GlaxoSmithKline said Monday that its rare disease unit formed earlier this year plans to target about 200 diseases.
NewsObserver
NewsObserver
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May